Athens Medical C.S.A Past Earnings Performance

Past criteria checks 2/6

Athens Medical C.S.A has been growing earnings at an average annual rate of 3.4%, while the Healthcare industry saw earnings growing at 12.2% annually. Revenues have been growing at an average rate of 6.8% per year. Athens Medical C.S.A's return on equity is 8.4%, and it has net margins of 3.6%.

Key information

3.4%

Earnings growth rate

3.4%

EPS growth rate

Healthcare Industry Growth13.4%
Revenue growth rate6.8%
Return on equity8.4%
Net Margin3.6%
Last Earnings Update30 Jun 2023

Recent past performance updates

Recent updates

Athens Medical C.S.A (ATH:IATR) Seems To Be Using A Lot Of Debt

Jun 09
Athens Medical C.S.A (ATH:IATR) Seems To Be Using A Lot Of Debt

There Are Reasons To Feel Uneasy About Athens Medical C.S.A's (ATH:IATR) Returns On Capital

May 09
There Are Reasons To Feel Uneasy About Athens Medical C.S.A's (ATH:IATR) Returns On Capital

Athens Medical C.S.A (ATH:IATR) Is Reinvesting At Lower Rates Of Return

Jan 05
Athens Medical C.S.A (ATH:IATR) Is Reinvesting At Lower Rates Of Return

Athens Medical C.S.A (ATH:IATR) Seems To Use Debt Quite Sensibly

Oct 04
Athens Medical C.S.A (ATH:IATR) Seems To Use Debt Quite Sensibly

There's Been No Shortage Of Growth Recently For Athens Medical C.S.A's (ATH:IATR) Returns On Capital

Aug 12
There's Been No Shortage Of Growth Recently For Athens Medical C.S.A's (ATH:IATR) Returns On Capital

There May Be Reason For Hope In Athens Medical C.S.A's (ATH:IATR) Disappointing Earnings

May 07
There May Be Reason For Hope In Athens Medical C.S.A's (ATH:IATR) Disappointing Earnings

Can Athens Medical C.S.A (ATH:IATR) Continue To Grow Its Returns On Capital?

Mar 10
Can Athens Medical C.S.A (ATH:IATR) Continue To Grow Its Returns On Capital?

Did Athens Medical Center's (ATH:IATR) Share Price Deserve to Gain 92%?

Feb 02
Did Athens Medical Center's (ATH:IATR) Share Price Deserve to Gain 92%?

Do Insiders Own Lots Of Shares In Athens Medical Center S.A. (ATH:IATR)?

Dec 27
Do Insiders Own Lots Of Shares In Athens Medical Center S.A. (ATH:IATR)?

What Can The Trends At Athens Medical Center (ATH:IATR) Tell Us About Their Returns?

Nov 30
What Can The Trends At Athens Medical Center (ATH:IATR) Tell Us About Their Returns?

Revenue & Expenses Breakdown
Beta

How Athens Medical C.S.A makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ATSE:IATR Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 232499430
31 Mar 232418420
31 Dec 222337420
30 Sep 222339410
30 Jun 2223410400
31 Mar 2223011390
31 Dec 2122612380
30 Jun 2120710350
31 Mar 211976340
31 Dec 201882340
30 Sep 201932340
30 Jun 20190-1340
31 Mar 201943330
31 Dec 191978320
30 Sep 191929310
30 Jun 1918711300
31 Mar 1918511300
31 Dec 1818311310
30 Sep 181808300
30 Jun 181775300
31 Mar 181734280
31 Dec 171693270
30 Sep 171705260
30 Jun 171707250
31 Mar 171695260
31 Dec 161673260
30 Sep 16167-4280
30 Jun 16158-12300
31 Mar 16155-18340
31 Dec 15158-16340
30 Sep 15147-26330
30 Jun 15150-25320
31 Mar 15151-16300
31 Dec 14149-19310
30 Sep 14127-34290
30 Jun 14131-32290
31 Mar 14139-36280
31 Dec 13142-39280
30 Sep 13189-22500
30 Jun 13193-21520

Quality Earnings: IATR has high quality earnings.

Growing Profit Margin: IATR's current net profit margins (3.6%) are lower than last year (4.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: IATR has become profitable over the past 5 years, growing earnings by 3.4% per year.

Accelerating Growth: IATR's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: IATR had negative earnings growth (-12.6%) over the past year, making it difficult to compare to the Healthcare industry average (0.3%).


Return on Equity

High ROE: IATR's Return on Equity (8.4%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.